Table 1.
Sample Characteristics
| Characteristics | Rise-uP (n=933) | CG (n=312) | p | |
|---|---|---|---|---|
| Sex | FemaleMale | 65%35% | 64%36% | n.s. |
| Age (years) | M (SD) | 42.0 (12.4) | 37.0 (12.6) | sig. |
| Height (cm) | M (SD) | 171 (11) | 172 (10) | n.s. |
| Weight (kg) | M (SD) | 77.5 (19.7) | 77·8 (18.5) | n.s. |
| Education level | Academic Non-academic |
29% 71% |
27% 73% |
n.s. |
| Employment | Yes No |
87% 13% |
87% 13% |
n.s. |
| Taking pain killer | Yes No |
36% 64% |
37% 63% |
n.s. |
| Risk of development of chronic pain | Low Medium High |
47% 36% 17% |
62% 28% 10% |
sig. |
| Recruitment channel | GP supplier Facebook supplier | 67%33% | 47%53% | sig. |
Notes: Overview of the patients’ characteristics both for the Rise-uP and the control group. All patients who were included to the study are displayed except those who withdrew consent resulting in N = 1245 (Rise-uP: 933 patients vs CG: 312 patients). “Sig.” indicates Bonferroni-corrected (α’ = ·01) significance (two-tailed).